Oct 6, 2022 5:17 AM
BACK TO TOP
KSE100
41,611.42
260.99
(0.63%)
ALLSHR
28,379.06
139.15
(0.49%)
KSE30
15,604.36
126.85
(0.82%)
KMI30
68,837.18
490.23
(0.72%)
BKTi
9,840.50
-28.89
(-0.29%)
OGTi
10,023.27
49.07
(0.49%)
KMIALLSHR
20,913.74
146.52
(0.71%)
PSXDIV20
13,487.42
47.79
(0.36%)
UPP9
10,547.40
38.87
(0.37%)
NITPGI
8,758.06
63.73
(0.73%)
NBPPGI
10,786.29
146.85
(1.38%)
MZNPI
8,801.12
36.48
(0.42%)
JSMFI
9,769.28
94.21
(0.97%)
ACI
8,462.46
104.61
(1.25%)
HBLTTI
10,174.76
04-10-2022
4.00
(0.04%)
Sanofi-Aventis Pakistan Limited
PHARMACEUTICALS
Rs.1,108.77
-89.23
(-7.45%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Wed, Oct 5, 2022 3:34 PM
REG
FUT
ODL
Open
1,260.00
High
1,260.00
Low
1,108.15
Volume
350
CIRCUIT BREAKER
1,108.15 — 1,287.85
DAY RANGE
1,108.15 — 1,260.00
52-WEEK RANGE
492.00 — 1,540.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
1,198.00
VAR
26.00
HAIRCUT
32.50
P/E Ratio (TTM) **
16.43
1-Year Change *
58.40%
YTD Change *
23.52%

No record found

Open
1,079.00
High
1,100.00
Low
1,079.00
Close
1,100.00
Change
-8.18%
LDCP
1,198.00
Volume
20
Total Trades
4
CIRCUIT BREAKER
1,078.20 — 1,317.80
DAY RANGE
1,079.00 — 1,100.00
Ask Price
1,120.00
Ask Volume
3
Bid Price
1,090.00
Bid Volume
6
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

The Company was incorporated in Pakistan in 1967 as a Public Limited Company under Companies Act, 1913 (now Companies Act, 2017). The Company is a subsidiary of Sanofi Foreign Participations B.V. registered in Netherlands. The ultimate parent of the Company is Sanofi S.A., France. The Company is engaged in the manufacturing, selling and trading of pharmaceutical and related products.

KEY PEOPLE
Mr. Asim JamalCEO
Mr. Syed Babar AliChairman
Mr. Muhammad AbuBakar SiddiqCompany Secretary
ADDRESS

Plot No 23, Sector 22 Korangi Industrial Area Karachi, Pakistan.

WEBSITE

www.sanofi.com.pk

REGISTRAR

FAMCO Associates (Pvt) Ltd 8-F, Next to Hotel Faran, Nursery, Block -6, P.E.C.H.S Shahrah e Faisal Karachi

AUDITOR

EY Ford Rhodes, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
10,693,864.90
Shares
9,644,800
Free Float
1,446,714
Free Float
15.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Aug 31, 2022Transmission of Financial Statements for the half-year ended June 30, 2022 View   PDF
Aug 25, 2022Financial results for the half year ended June 30, 2022 View   PDF
May 6, 2022 Transmission of Quarterly Accounts for the Period Ended March 31, 2022 View   PDF
Apr 28, 2022Financial Results for the Quarter Ended March 31, 2022 View   PDF
Apr 1, 2022Transmission of Annual Report for the Year Ended December 31, 2021 View   PDF
Mar 25, 2022Financial Results for the Year Ended December 31, 2021 View   PDF
Oct 28, 2021 Transmission of Financial Statements for Period Ended September 30, 2021 View   PDF
Oct 27, 2021Financial Results for the Period Ended September 30, 2021 View   PDF
Aug 27, 2021SAPL Sanofi-Aventis Pakistan Limited - Half year ended June 30, 2021 Financial Statements View   PDF
Aug 26, 2021Financial Results for the Six Months Ended June 30, 2021 View   PDF
DateTitleDocument
Sep 16, 2022Notice of Extraordinary General Meeting View   PDF
Sep 15, 2022Notice of Extraordinary General Meeting (Pre-Publication) View   PDF
Aug 17, 2022Board Meeting for the half year ended June 30, 2022 View   PDF
Apr 25, 2022Certified Extract of Resolutions passed at 54th Annual General Meeting View   PDF
Apr 19, 2022Board Meeting for the Quarter ended March 31, 2022 View   PDF
Apr 4, 2022Notice of Annual General Meeting for the Year Ended December 31, 2021 View   PDF
Mar 17, 2022Board Meeting for the Year ended December 31, 2021 View   PDF
Oct 14, 2021Board Meeting for the Period Ended September 30, 2021 View   PDF
Aug 17, 2021Board Meeting View   PDF
Apr 23, 2021Certified Extract of Resolutions passed at 53rd Annual General Meeting View   PDF
DateTitleDocument
Aug 16, 2022Disclosure of Material information View   PDF
Jul 21, 2022Notice of Book Closure View   PDF
Jun 29, 2022Material Information View   PDF
May 6, 2022Credit of Final Cash Dividend for the Year 2021 View   PDF
May 6, 2022Material Information View   PDF
Apr 28, 2022Material Information View   PDF
Dec 30, 2021Material Information View   PDF
Dec 28, 2021Material Information
REVOKED
View   PDF
Dec 20, 2021Material Information View   PDF
Nov 22, 2021Change of Company Secretary View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2021202020192018
Sales15,880,93214,107,80214,500,67812,960,839
Profit after Taxation905,952493,067154,836612,792
EPS93.9351.1216.0563.54
Q2 2022Q1 2022Q3 2021Q2 2021
Sales5,140,1954,383,6493,849,2024,492,770
Profit after Taxation(25,868)214,725(94,610)198,113
EPS(2.68)22.26(9.81)20.54
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2021202020192018
Gross Profit Margin (%)25.9626.9725.6930.45
Net Profit Margin (%)5.703.491.074.73
EPS Growth (%)83.74218.50(74.74)(39.09)
PEG0.110.07(0.69)(0.30)

Payouts

DateFinancial ResultsDetailsBook Closure
March 25, 2022 3:38 PM31/12/2021(YR) 300%(F) (D) 17/04/2022 - 25/04/2022
March 2, 2021 2:59 PM31/12/2020(YR) 200%(F) (D) 13/04/2021 - 23/04/2021
March 3, 2020 3:51 PM31/12/2019(YR) 80% (D) 13/05/2020 - 20/05/2020
March 1, 2019 1:38 PM31/12/2018(YR) 300% (F) (D) 17/04/2019 - 23/04/2019
March 7, 2018 3:01 PM31/12/2017(YR) 450% (D) 20/04/2018 - 26/04/2018
March 8, 2017 12:53 PM31/12/2016(YR) 300% (D) 19/04/2017 - 25/04/2017
February 25, 2016 10:14 AM31/12/2015(YR) 30% (D) 19/04/2016 - 25/04/2016
March 12, 2015 1:37 PM31/12/2014(YR) 70% (D) 21/04/2015 - 27/04/2015
February 26, 2014 2:19 PM31/12/2013(YR) 100% (D) 18/04/2014 - 25/04/2014
February 28, 2013 10:15 AM31/12/2012(YR) 125% (F) (D) 19/04/2013 - 25/04/2013

Financial Reports